SCHEDULE: Wellington Management Discloses 8% Stake in AtriCure

Wellington Management Group LLP and its affiliates have reported an 8.0% beneficial ownership stake in AtriCure, Inc. common stock.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, collectively reported beneficial ownership of 3,969,269 shares of AtriCure, Inc. common stock.
• This aggregate beneficial ownership represents an 8.0% stake in AtriCure, Inc.'s common stock as of June 30, 2025.
• Wellington Management Company LLP, specifically, reported shared dispositive power over 3,377,947 shares, which constitutes 6.8% of the class.
• The reporting entities hold shared voting power over 2,342,505 shares.
• The filing was made under Rule 13d-1(b), certifying that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a routine disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance. However, a significant institutional stake can be viewed as a neutral to slightly positive signal of investor interest.

Positives

• A major institutional investor, Wellington Management Group LLP, has disclosed a significant 8.0% beneficial ownership stake in AtriCure, Inc., which can be interpreted as a signal of confidence in the company's prospects.

Future Outlook

NA

Industry Context

This filing indicates continued institutional interest in the medical device sector, specifically in companies like AtriCure, Inc., which operates in the cardiac surgery and atrial fibrillation treatment space. The significant stake by a prominent asset manager like Wellington Management suggests a belief in the long-term value or growth potential within this specialized segment of healthcare.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence investor perception and potentially stock liquidity.

Key Dates

Keywords

AtriCure, Wellington Management, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Medical Devices